Cargando...
Neoadjuvant Therapy in High-Risk Prostate Cancer
High-risk prostate cancer (PCa) is associated with higher rates of biochemical recurrence, clinical recurrence, metastasis, and PCa-specific death, compared to low-and intermediate-risk disease. Herein, we review the various definitions of high-risk PCa, describe the rationale for neoadjuvant therap...
Guardado en:
| Publicado en: | Indian J Urol |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Wolters Kluwer - Medknow
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7759181/ https://ncbi.nlm.nih.gov/pubmed/33376260 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/iju.IJU_115_20 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|